Elevated levels of cerebrospinal fluid (CSF) AMPH have been documented in some studies of patients with Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) who exhibit abnormal tau levels. Here, MAPT is linked to Alzheimer disease.